Browse > Home / Cresco Labs Rebrands New York Medical Cannabis Dispensaries and Launches Delivery in the New Hartford Area – New Cannabis Ventures

Cresco Labs Rebrands New York Medical Cannabis Dispensaries and Launches Delivery in the New Hartford Area – New Cannabis Ventures

February 27, 2020

Cresco Labs Announces the Opening of its First Four Sunnyside* Dispensaries in New York and the Launch of its Medical Cannabis Delivery Program in the New Hartford Area

Stores in Brooklyn, Huntington Station, New Hartford and Bardonia are the first dispensaries to operate under the Companys national retail brand on the East Coast

CHICAGO, February 27, 2020–(BUSINESS WIRE)–Cresco Labs(CSE:CL)(OTCQX:CRLBF) (Cresco or the Company), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the conversion of four dispensaries to Crescos nationwide retail brand, Sunnyside*, in the Williamsburg neighborhood in Brooklyn, Huntington Station, New Hartford and Bardonia, New York. Cresco also launched today a home delivery service for medical cannabis patients in the New Hartford area of New York. Patients can place orders for home delivery for a variety of products including vape pens and cartridges, topical creams, oral tinctures and capsules atSunnyside.shop. Cresco plans to roll out its medical cannabis home delivery program to the three other communities with Sunnyside* locations in the coming months.

These dispensaries in the state of New York are the first stores to be rebranded under Crescos national retail brand on the East Coast. Cresco holds one of the 10 vertically integrated cannabis business licenses granted in the state by the New York State Department of Health. Each license gives the operator the right to operate one cultivation facility and four dispensaries in New York.

As we continue to build our national retail brand and consolidate the five dispensary brands we operate around the country under the Sunnyside* name, we remain focused on ensuring that we deliver against the promise of what Sunnyside* stands forwellness, education and convenience, said Charlie Bachtell, Cresco Labs CEO and Co-founder.

New York has a growing medical cannabis patient program of more than 114,000 people who look to dispensaries and their cannabis product forms to treat a variety of qualifying conditions and critical illnesses. With Sunnyside*, we aim to provide a best-in-class shopping experience through ongoing education, product availability and technology.

Charlie Bachtell, Cresco Labs CEO and Co-founder

The ease of home delivery provides the convenience that many living in New York will appreciate with the benefit of the quality and consistency that regulated, third-party tested, cannabis products can provide. Home delivery plays a critical role in our ecommerce strategy, and we are excited to offer this service to reach medical cannabis patients in our communities with the right products they need.

Registered medical cannabis patients can place a home delivery order seven days a week at Sunnyside.shop with a minimum order of $80 required for delivery service. Free delivery is available for orders of $150 or more. Distributed from Crescos Sunnyside* dispensary in New Hartford, delivery services are available for patients in the following communities: New Hartford, Utica, Marcy, Whitesboro, Oriskany, Clinton, Sauquoit, Frankfurt and Rome.

About Cresco Labs

Cresco Labs is one of the largest vertically-integrated multi-state cannabis operators in the United States. Cresco is built to become the most important company in the cannabis industry by combining the most strategic geographic footprint with one of the leading distribution platforms in North America. Employing a consumer-packaged goods (CPG) approach to cannabis, Crescos house of brands is designed to meet the needs of all consumer segments and includes some of the most recognized and trusted national brands including Cresco, Remedi and Mindys, a line of edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside*, Crescos national dispensary brand, is a wellness-focused retailer designed to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco has launched the industrys first national comprehensive Social Equity and Educational Development (SEED) initiative designed to ensure that all members of society have the skills, knowledge and opportunity to work in and own businesses in the cannabis industry. Learn more about Cresco Labs atwww.crescolabs.com.

Original press release